Obstetrics & Gynecology Doctors in Iowa Medicare Details, Address, Contact

383 Obstetrics & Gynecology doctors found. Showing 381 - 383

Anne Marie Sayre, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6000 University Ave, Ste 203, West Des Moines, IA 50266 Phone: 515-241-2200    Fax: 515-241-2201

Dr. Alvadore Perry Osborn, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 205, West Des Moines, IA 50266 Phone: 515-875-9290    Fax: 515-875-9291

Dr. Bernard James Munro, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2501 Westown Pkwy, Suite 1101, West Des Moines, IA 50266 Phone: 515-267-8300    Fax: 515-267-8872

News Archive

Viewpoints: 'Bailout' isn't the right target for GOP; Republican senators' alternative 'looks inferior;' uninsured are not rushing to health market

Ever since the housing market collapse, nothing stokes the flames of public outrage quite like the phrase "government bailout." It's become the condemnation of choice for both parties when faced with a policy they don't like.

Time is right to make cancer control a development priority

For public health, the complexity of cancer control has increased enormously following the shift of the disease burden from wealthy to less affluent countries. Cancer causes around 7.9 million deaths worldwide each year. Of these deaths, more than 72% are now occurring in low- and middle-income countries. This is a shocking statistic, with huge implications for human suffering, health systems, health budgets, and the drive to reduce poverty.

UCLA researchers identify new biomarker that can help track amyloid beta in Alzheimer's

UCLA researchers have identified a new biomarker that could help them track how effectively the immune system is able to clear the brain of amyloid beta, which forms the plaques considered one of the hallmarks of Alzheimer's disease.

Oral chemotherapy agent Orathecin™ (rubitecan) capsules accepted by FDA for filing

SuperGen Inc. announced today that the Food and Drug Administration (FDA) has officially accepted the Orathecin™ (rubitecan) capsules' New Drug Application (NDA) for filing. Orathecin, an investigational anticancer compound, is an oral chemotherapy agent that has been investigated as a treatment for pancreatic cancer patients who have failed at least one prior chemotherapy.

Read more Medical News

› Verified 6 days ago

• «
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20(current)